Use of selective serotonin reuptake inhibitors during pregnancy and breastfeeding has both benefits and risks

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.3, 2006-03, pp. : 22-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

By Mourilhe P. Stokes P.E.

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 57-82

Adis International

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

By Alwan Sura Friedman Jan M.

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 493-509

Adis International

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

The safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite